← All stocks

Axogen, Inc.

AXGN Net selling
CIK 0000805928 #1882 in the set updated 17 Sep 2026
Bought (120 mo)
$2.12M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$88.03M
$1.43M on a plan · $16.17M straight out of an exercise
Sold at will
$70.44M
93 of 148 sales
Net
−$85.92M
−$68.33M against sales at will

By person

35 insiders · 255 transactions
4.0×

Michael Dale holds only 4.0 times base salary in stock. $3.16M of shares against $775.87K in salary for 2025.

Salary from the company's own proxy. The shares are what Michael Dale last reported holding, valued at $49.70, the price Common Stock was last bought or sold at on the open market here, on 2 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
EW Healthcare Partners, L.P. entity
10% owner
$22.70M (1)
−$22.70M
3,711,111
6.90%
$184.43M
−23.7%
NEELS GUIDO J
Director
$61.10K (1)
$22.74M (2)
−$22.68M
3,457,854
6.43%
$171.84M
−23.5%
Grooms Jamie Mark
Director
$9.19M (13)
−$9.19M
19,065
0.0355%
$947.47K
−94.3%
Freitag Gregory Gene
Director
$4.15M (15)
−$4.15M
283,498
0.5273%
$14.09M
+429.5%
Began Marc A
EVP & General Counsel
$3.88M (3) scheduled
−$3.88M
50,135
0.0933%
$2.49M
Burke William P. Mr.
Director
$65.60K (1)
$2.86M (14) scheduled
−$2.80M
14,250
0.0265%
$708.18K
Weiler Kathy Johnson
Director
$2.78M (6) scheduled
−$2.78M
0
0.0000%
$0.00
DALE MICHAEL D
Chief Executive Officer
$2.67M (2)
−$2.67M
63,537
0.1182%
$3.16M
Zaderej Karen L.
CEO
$1.09M (2)
$3.48M (13)
−$2.39M
1,143,788
2.13%
$56.84M
+469.7%
MARIANI PETER J
EVP & Chief Financial Officer
$25.00K (1)
$2.23M (16) scheduled
−$2.21M
63,603
0.1183%
$3.16M
+1,240%
JOHNSON JOHN
Director
$1.91M (6) scheduled
−$1.91M
14,150
0.0263%
$703.21K
Wendell Amy McBride
Director
$447.94K (4)
$2.14M (7) scheduled
−$1.69M
107,976
0.2008%
$5.37M
TYNDALL JOSEPH A.
Director
$1.49M (7) scheduled
−$1.49M
10,650
0.0198%
$529.27K
+321.8%
Donovan Michael Patrick
VP Operations
$1.15M (12)
−$1.15M
54,250
0.1009%
$2.70M
DeVinney Erick Wayne
Chief Innovation Officer
$1.11M (9)
−$1.11M
262,781
0.4888%
$13.06M
+2,322%
Hartley Lindsey Marie
CFO
$942.20K (5) scheduled
−$942.20K
65,146
0.1212%
$3.24M
+182.7%
THOMAS PAUL
Director
$633.71K (1)
−$633.71K
32,395
0.0603%
$1.61M
Hansen David K
VP Finance & Treasurer
$452.60K (1)
−$452.60K
25,588
0.0476%
$1.27M
+149.4%
MCCARREY SHAWN F
SVP Sales
$434.70K (1)
−$434.70K
82,921
0.1542%
$4.12M
+141.0%
Kemp Jens
Chief Marketing Officer
$428.29K (2)
−$428.29K
72,451
0.1348%
$3.60M
+125.6%
Rudelius Robert James
Director
$290.57K (1)
−$290.57K
48,183
0.0896%
$2.39M
+107.0%
Blackford Quentin S.
Director
$217.67K (3)
+$217.67K
27,335
0.0508%
$1.36M
Quackenbush Doris
Sales VP
$168.72K (1)
−$168.72K
92,416
0.1719%
$4.59M
−4.0%
Billet Isabelle
Chief Strategy and BD Officer
$85.14K (13)
$11.56K (1)
+$73.58K
25,065
0.0466%
$1.25M
+563.1%
Scopelianos Angelo
Chief R&D Officer
$62.94K (4) scheduled
−$62.94K
57,994
0.1079%
$2.88M
+658.9%
Gold Mark Stephen
Director
$52.39K (6)
+$52.39K
601,741
1.12%
$29.90M
−5.9%
Levine Alan M
Director
$43.21K (1)
−$43.21K
50,893
0.0947%
$2.53M
Engels John P
VP
$30.00K (1)
+$30.00K
98,425
0.1831%
$4.89M
+4.2%
MARTINEZ MARIA D.
Chief Human Resources Officer
$30.26K (1)
$60.11K (2)
−$29.85K
30,476
0.0567%
$1.51M
Leach Kevin
Vice President
$15.00K (1)
+$15.00K
2,000
0.0037%
$99.39K
Friedman Mark Louis
VP Regulatory Affairs & Policy
$11.67K (2)
−$11.67K
24,343
0.0453%
$1.21M
+105.0%
Naor Nir
CFO
260,868
0.4852%
$12.96M
Ottinger Bradley
General Counsel and CCO
23,627
0.0439%
$1.17M
+468.2%
Sandberg Eric
Chief Commercial Officer
16,081
0.0299%
$799.18K
Gingrich Jon S.
Chief Commercial Officer
4,190
0.0078%
$208.23K
+150.4%
Insider
Date
Role
Action
Shares
Price
Amount
Wendell Amy McBride
12 May 2023
Director
Exercised, kept
3,750
$9.22
$34.58K
Wendell Amy McBride
12 May 2023
Director
Exercised, kept
25,000
$9.22
$230.50K
DeVinney Erick Wayne
27 Dec 2022
VP Peripheral Nerve Science
Exercised, kept
20,000
$5.09
$101.80K
Zaderej Karen L.
15 Dec 2022
CEO
Exercised, kept
26,746
$5.09
$136.14K
MARIANI PETER J
14 Dec 2022
EVP & Chief Financial Officer
Exercised, kept
19,364
$5.04
$97.59K
Freitag Gregory Gene
25 Jul 2022
Director
Exercised, kept
83,000
$3.38
$280.54K
Donovan Michael Patrick
22 Feb 2022
VP Operations
Exercised, kept
5,000
$5.45
$27.25K
Donovan Michael Patrick
22 Feb 2022
VP Operations
Exercised, kept
10,000
$5.09
$50.90K
DeVinney Erick Wayne
15 Dec 2021
VP Peripheral Nerve Science
Exercised, kept
10,000
$3.67
$36.70K
Zaderej Karen L.
24 Nov 2021
CEO
Exercised, kept
52,375
$8.95
$468.76K
Zaderej Karen L.
13 Aug 2021
CEO
Exercised, kept
46,500
$3.67
$170.66K
Zaderej Karen L.
12 Aug 2021
CEO
Exercised, kept
8,254
$5.09
$42.01K
Zaderej Karen L.
10 Aug 2021
CEO
Exercised, kept
75,000
$5.09
$381.75K
Freitag Gregory Gene
17 Jun 2021
Director
Exercised, kept
9,250
$19.17
$177.32K
Freitag Gregory Gene
4 Jun 2021
Director
Exercised, kept
24,000
$3.67
$88.08K
Freitag Gregory Gene
26 May 2021
Director
Exercised, kept
50,000
$8.95
$447.50K
Freitag Gregory Gene
26 May 2021
Director
Exercised, kept
15,000
$5.45
$81.75K
Freitag Gregory Gene
26 May 2021
Director
Exercised, kept
6,000
$5.45
$32.70K
Freitag Gregory Gene
26 May 2021
Director
Exercised, kept
9,000
$5.09
$45.81K
Freitag Gregory Gene
26 May 2021
Director
Exercised, kept
22,954
$3.67
$84.24K
NEELS GUIDO J
19 May 2021
Director
Exercised, kept
15,000
$5.09
$76.35K
NEELS GUIDO J
19 May 2021
Director
Exercised, kept
25,000
$3.80
$95.00K
DeVinney Erick Wayne
28 Apr 2021
VP of Clin. & Trans. Sciences
Exercised, kept
10,000
$2.86
$28.60K
Zaderej Karen L.
16 Apr 2021
CEO
Exercised, kept
100,000
$5.09
$509.00K
Zaderej Karen L.
25 Mar 2021
CEO
Exercised, kept
34,500
$3.67
$126.62K
Donovan Michael Patrick
5 Feb 2021
VP Operations
Exercised, kept
20,000
$5.14
$102.80K
Zaderej Karen L.
23 Dec 2020
CEO
Exercised, kept
19,375
$4.81
$93.19K
DeVinney Erick Wayne
15 Dec 2020
VP, Clinical&Translational Sc
Exercised, kept
15,000
$4.81
$72.15K
Friedman Mark Louis
3 Dec 2020
VP,Regulatory & Quality
Exercised, kept
3,187
$3.67
$11.70K
Friedman Mark Louis
3 Dec 2020
VP,Regulatory & Quality
Exercised, kept
625
$4.81
$3.01K
Freitag Gregory Gene
15 Sep 2020
Director
Exercised, kept
13,046
$3.67
$47.88K
Freitag Gregory Gene
29 May 2020
General Counsel
Exercised, kept
125,000
$3.50
$437.50K
Donovan Michael Patrick
28 May 2020
VP Operations
Exercised, kept
5,000
$5.14
$25.70K
Donovan Michael Patrick
28 May 2020
VP Operations
Exercised, kept
10,000
$3.67
$36.70K
DeVinney Erick Wayne
28 Apr 2020
VP, Clinical&Translational Sc
Exercised, kept
2,530
$0.27
$683.10
Zaderej Karen L.
16 Apr 2020
CEO
Exercised, kept
11,625
$4.81
$55.92K
Rudelius Robert James
1 Jan 2020
Director
Exercised, kept
13,000
$2.75
$35.75K
Donovan Michael Patrick
8 Oct 2019
VP Operations
Exercised, kept
1,500
$2.90
$4.35K
Donovan Michael Patrick
8 Oct 2019
VP Operations
Exercised, kept
5,000
$4.81
$24.05K
Zaderej Karen L.
29 May 2019
CEO
Exercised, kept
18,056
$0.27
$4.88K
Zaderej Karen L.
19 Nov 2018
CEO
Exercised, kept
70,000
$2.74
$191.80K
Zaderej Karen L.
19 Nov 2018
CEO
Exercised, kept
30,000
$2.74
$82.20K
DeVinney Erick Wayne
13 Nov 2018
VP, Clinical&Translational Sc
Exercised, kept
274
$0.27
$73.98
DeVinney Erick Wayne
13 Nov 2018
VP, Clinical&Translational Sc
Exercised, kept
35,000
$2.74
$95.90K
Grooms Jamie Mark
20 Sep 2018
Director
Exercised, kept
12,000
$2.75
$33.00K
Grooms Jamie Mark
20 Sep 2018
Director
Exercised, kept
494
$0.27
$133.38
MCCARREY SHAWN F
7 Aug 2018
SVP Sales
Exercised, kept
55,000
$3.67
$201.85K
Zaderej Karen L.
2 Aug 2018
CEO
Exercised, kept
175,000
$2.74
$479.50K
Rudelius Robert James
8 Jun 2018
Director
Exercised, kept
12,000
$2.75
$33.00K
Gold Mark Stephen
1 Jun 2018
Director
Exercised, kept
15,000
$14.85
$222.75K
Donovan Michael Patrick
26 Mar 2018
VP Operations
Exercised, kept
30,000
$2.74
$82.20K
Hansen David K
22 Mar 2018
VP Finance & Treasurer
Exercised, kept
1,500
$2.75
$4.13K
Hansen David K
22 Mar 2018
VP Finance & Treasurer
Exercised, kept
35,000
$2.74
$95.90K
Freitag Gregory Gene
21 Mar 2018
General Counsel & SVP BD
Exercised, kept
15,000
$4.81
$72.15K
Freitag Gregory Gene
21 Mar 2018
General Counsel & SVP BD
Exercised, kept
16,000
$2.46
$39.36K
Freitag Gregory Gene
1 Mar 2018
General Counsel & SVP BD
Exercised, kept
36,000
$2.74
$98.64K
Gold Mark Stephen
13 Nov 2017
Director
Exercised, kept
15,000
$5.09
$76.35K
Grooms Jamie Mark
1 Nov 2017
Director
Exercised, kept
14,379
$0.27
$3.88K
Friedman Mark Louis
24 Oct 2017
VP,Regulatory & Quality
Exercised, kept
16,829
$1.07
$18.01K
Friedman Mark Louis
24 Oct 2017
VP,Regulatory & Quality
Exercised, kept
4,375
$4.81
$21.04K
Friedman Mark Louis
24 Oct 2017
VP,Regulatory & Quality
Exercised, kept
5,313
$3.67
$19.50K
Friedman Mark Louis
24 Oct 2017
VP,Regulatory & Quality
Exercised, kept
1,250
$5.45
$6.81K
Friedman Mark Louis
24 Oct 2017
VP,Regulatory & Quality
Exercised, kept
40,000
$2.74
$109.60K
Freitag Gregory Gene
25 Sep 2017
General Counsel & SVP BD
Exercised, kept
10,000
$2.74
$27.40K
Rudelius Robert James
8 Sep 2017
Director
Exercised, kept
20,000
$3.50
$70.00K
Freitag Gregory Gene
27 Aug 2017
General Counsel & SVP BD
Exercised, kept
23,000
$2.74
$63.02K
Gold Mark Stephen
30 May 2017
Director
Exercised, kept
5,000
$8.95
$44.75K
Gold Mark Stephen
22 May 2017
Director
Exercised, kept
15,000
$4.81
$72.15K
Donovan Michael Patrick
14 Mar 2017
VP Operations
Exercised, kept
5,000
$2.74
$13.70K
Donovan Michael Patrick
14 Mar 2017
VP Operations
Exercised, kept
4,659
$0.27
$1.26K
DeVinney Erick Wayne
14 Mar 2017
VP, Clinical&Translational Sc
Exercised, kept
359
$0.27
$96.93
DeVinney Erick Wayne
14 Mar 2017
VP, Clinical&Translational Sc
Exercised, kept
4,659
$0.27
$1.26K
Freitag Gregory Gene
30 Dec 2016
General Counsel & SVP BD
Exercised, kept
23,000
$2.74
$63.02K
Showing 250 of 255 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 478
Amendments (4/A) skipped 11
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 48
Sales at will 93
Transactions with no price 0
Shares from compensation/vesting 5,060,938
Sales filed before the plan box existed 57
History held since 13 Oct 2016